google it. of course, each manufacturing CRL has its own 'life' so it is very difficult to predict how long this will be, but it should delay AZN for at least 12 months one would think.
Gizmondo is correct, never fall in love w a stock/company if you want to make $$ (unless you are Warren Buffet). This is a business and the goal is to profit, especially in Bio world where products can go obsolete quickly based on many potential events. Take da money and run!
Lurker, I give the odds of what you are describing at 10% because MDVN has a lot of value for many BP's and Bio's interested in enlargening their Cancer portfolios. What is baffling is why it took so long to get to this point.
Although it is an interesting strategic move, DHT on a standlone basis is worth alot more than $6.3/share
why would DHT BOD (and shareholders) agree to a merger at only a 20% premium ?
'The market currently doesn't think so, it's worth 5.43'
Mr Market is not always right (but it can certainly be wrong for a longer time period than many of us can sustain). I am not adverse to a BO, just trying to get my point across that a 20% premmie may not get it done. But a 40% premmie would certainly make me think twice.